Skip to main content
. 2021 Jan 15;26(2):431. doi: 10.3390/molecules26020431

Scheme 4.

Scheme 4

Putative SAR and structure–solubility relationship considerations for the analogues of 22 reported in [78,80] (IEGCL: inhibitory effect in growth of tumor cell lines).